济南男性医院哪家好(济南市看前列腺炎) (今日更新中)

The stockpiling frenzy that occurred in the spring during the first wave of COVID-19 may rear its ugly head again.Research from Inmar Intelligence shows that 57% of shoppers are planning to rebuild their stockpile as worldwide coronavirus cases surge in what experts call a second wave.In the months following the pandemic's beginning, cleaning supplies and toilet paper disappeared from store shelves as quickly as they were stocked.According to Inmar, 64% of shoppers said they took part in the spring stockpiling.By far, toilet paper (67%) and hand sanitizer (57%) are on top of the list when it comes to products that shoppers plan to hoard should they find it necessary to create another stockpile.Inmar Intelligence says it is now the responsibility of retailers to make sure supply meets demand as communities once again face possible shutdowns in the face of rising COVID-19 cases."Today's shoppers still have concerns around safety, availability, and convenience, and will continue to look to their local retailers to deliver consistency and seamless customer service across all touchpoints," said Inmar Chairman and CEO David Mounts in a press release. "As we enter one of the busiest shopping seasons, it will be important for retailers not only to prepare for this new surge in demand but also to deliver value to customers during this time of crisis to maintain heightened trust and customer loyalty."The firm stated that 27% of shoppers are considering a winter stockpile because they're concerned certain products won't be in stock when they need them.In comparison, another 27% are concerned about in-store shopping safety if a second wave were to happen.Other products that consumers have stocked up or plan to stock up on are paper towels (52%), disinfecting wipes (53%), and canned goods (54%).45% of shoppers said they plan to purchase new items such as frozen dinners, pasta, snacks, and cleaning products, which weren't in their first stockpile.This story was first reported by Jeff Tavss at KSTU in Salt Lake City, Utah. 2051

The wife of a Marine veteran self-deported to Mexico on Thursday rather than be arrested by immigration officials.The Associated Press reports that Alejandra Juarez and her eight-year-old daughter boarded a plane at Orlando International Airport Thursday after a teary goodbye with her husband and 16-year-old daughter.Jaurez had been told earlier this week that she would be deported Aug. 3 after Rep. Darren Soto could not pass legislation to keep Jaurez in the US.In a statement issued to CNN earlier this week, ICE says "Juarez was initially apprehended and removed from the country after attempting to enter illegally from Mexico in 1998. He said she later illegally re-entered the United States after being removed — which is a felony." 765

The state of play in key races has shifted since election night almost one week ago, offering a different picture of where the balance of power will stand in Washington come January.Democrats have taken the lead in a handful of key House races while the margin in Florida's Senate race has narrowed, forcing a recount.A key US Senate race in Arizona was settled on Monday night -- six days after Election Day -- when Republican Rep. Martha McSally conceded to Democratic Rep. Kyrsten Sinema.Two governors' races remain undecided in Georgia and Florida.Here's a breakdown of where key races stand: 605

The U.S. will pay drug company Pfizer .95 billion to produce and deliver 100 million doses of the company's COVID-19 vaccine candidate should the drug prove effective in human trials the company said in a press release on Wednesday.Pfizer will deliver the vaccine if and when the drug receives Emergency Use Authorization from the FDA after a large-scale Phase 3 trial.According to the reports, the deal includes an option for the government to purchase an additional 500 million doses of the vaccine.“Expanding Operation Warp Speed’s diverse portfolio by adding a vaccine from Pfizer and BioNTech increases the odds that we will have a safe, effective vaccine as soon as the end of this year,” Health and Human Services Sec. Alex Azar said in a statement. “Depending on success in clinical trials, today’s agreement will enable the delivery of approximately 100 million doses of this vaccine to the American people.”Pfizer and German firm BioNTech are working together to develop the vaccine.On Monday, Pfizer said in a press release that results from Phases 1 and 2 of a German trial indicated that the drug "could potentially be administered safely, with a manageable tolerability profile," according to data from the tests.Biotech company Moderna is also working to develop a coronavirus vaccine. That candidate will move into Phase 3 testing by the end of the month, and the government has also agreed to purchase and distribute the drug should the large-scale test prove effective. 1497

The wild is calling, and we're answering. Reserve yours 7.13.20. #FordBronco pic.twitter.com/2LEDH5FNtr— Ford Motor Company (@Ford) June 29, 2020 153

来源：资阳报